X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

EMBRACING SUPPORT
CLICK TO SWITCH

KNOW WHERE TO FIND SUPPORT DURING YOUR RELAPSING MS TREATMENT

An article written by a support partner sharing his experience of supporting his wife through her relapsing MS journey

BEING A SUPPORT PARTNER: THE POWER OF YOUR PRESENCE

By Jason, Husband, RMS Support Partner

Jason doesn’t have relapsing MS, but he lives experiences it every day through his wife, Kimberly. Here is what being a Support Partner means to him…

READ MORE


An article written by a LEMTRADA patient sharing how he handled talking to his employer about his relapsing MS

A SUPPORTIVE EMPLOYER CAN HELP WITH RELAPSING MS

By Donnie, Father, Husband, Project Leader, Former Athlete

One of the challenges for people with relapsing MS is talking to an employer about their condition. Here’s how I handled it.

READ MORE


TAP TO SWITCH
Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: